Atherosclerosis
Volume 207, Issue 1 , Pages 1-7 , November 2009

The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: A tribute to the late Dr. Yoshio Watanabe

Received 8 February 2009 ,Revised 13 March 2009 ,Accepted 17 March 2009.

References 

  1. Watanabe Y. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis. 1980;36:261–268
  2. Goldstein JL, Kita T, Brown MS. Defective lipoprotein receptors and atherosclerosis: lessons from an animal counterpart of familial hypercholesterolemia. N Engl J Med. 1983;309:288–296
  3. Watanabe Y. Studies on characteristics of spontaneously hyperlipemic rabbits and development of the strains with such property. Bull Azabu Vet Coll. 1977;2:99–124(in Japanese)
  4. Watanabe Y, Ito T, Kondo T. Breeding of a rabbit strain of hyperlipidemia and characteristics of the strain. Exp Anim. 1977;26:35–42(in Japanese)
  5. Goldstein JL, Brown MS. Binding and degradation of low density lipoproteins by cultured human fibroblasts, comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974;249:5153–5162
  6. Endo A, Kuroda M, Tsujita Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot (Tokyo). 1976;29:1346–1348
  7. Tanzawa K, Shimada Y, Kuroda M, Tsujita Y, Arai M, Watanabe Y. WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett. 1980;118:81–84
  8. Kita T, Brown MS, Watanabe Y, Goldstein JL. Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia. Proc Natl Acad Sci USA. 1981;78:2268–2272
  9. Attie AD, Pittman RC, Watanabe Y, Steinberg D. Low density lipoprotein receptor deficiency in cultured hepatocytes of the WHHL rabbit. J Biol Chem. 1981;256:9789–9792
  10. Havel RJ, Kita T, Kotite L, et al. Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. Arteriosclerosis. 1982;2:467–474
  11. Kita T, Goldstein JL, Brown MS, et al. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor. Proc Natl Acad Sci USA. 1982;79:3623–3627
  12. Kita T, Brown MS, Bilheimer DW, Goldstein JL. Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits. Proc Natl Acad Sci USA. 1982;79:5693–5697
  13. Dietschy JM, Kita T, Suckling KE, Goldstein JL, Brown MS. Cholesterol synthesis in vivo and in vitro in the WHHL rabbit, an animal with defective low density lipoprotein receptors. J Lipid Res. 1983;24:469–480
  14. Schneider WJ, Brown MS, Goldstein JL. Kinetic defects in the processing of the low density lipoprotein receptor in fibroblasts from WHHL rabbits and a family with familial hypercholesterolemia. Mol Biol Med. 1983;1:353–367
  15. Yamamoto T, Bishop RW, Brown MS, Goldstein JL, Russell DW. Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit. Science. 1986;232:1230–1237
  16. Bilheimer DW, Watanabe Y, Kita T. Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia. Proc Natl Acad Sci USA. 1982;79:3305–3309
  17. Pittman RC, Carew TE, Attie AD, et al. Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits. J Biol Chem. 1982;257:7994–8000
  18. Hornick CA, Kita T, Hamilton RL, Kane JP, Havel RJ. Secretion of lipoproteins from the liver of normal and Watanabe heritable hyperlipidemic rabbits. Proc Natl Acad Sci USA. 1983;80:6096–6100
  19. Son YC, Zilversmit DB. Increased lipid transfer activities in hyperlipidemic rabbit plasma. Arteriosclerosis. 1986;6:345–351
  20. Nakamura M, Taniguchi S, Ishida BY, Kobayashi K, Chan L. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice, role of apoB mRNA editing in lipoprotein phenotype expression. Arterioscler Thromb Vasc Biol. 1998;18:747–755
  21. Ishibashi S, Goldstein JL, Brown MS, Herz J, Buma DK. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest. 1994;93:1885–1893
  22. Agellon LB, Walsh A, Hayek T, et al. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem. 1991;266:10796–10801
  23. Kozarsky KF, Bonen DK, Giannoni F, et al. Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits. Hum Gene Ther. 1996;7:943–957
  24. Hilano K, Min J, Funahashi T, Davidson NO. Cloning and characterization of the rat apobec-1 gene: a comparative analysis of gene structure and promoter usage in rat and mouse. J Lipid Res. 1997;38:1103–1119
  25. Li X, Catalina F, Grundy SM, Patel S. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48 relative to B-100-containing lipoproteins. J Lipid Res. 1996;37:210–220
  26. González-Navarro H, Nong Z, Amar MJ, et al. The ligand-binding function of hepatic lipase modulates the development of atherosclerosis in transgenic mice. J Biol Chem. 2004;279:45312–45321
  27. Buja LM, Kita T, Goldstein JL, Watanabe Y, Brown MS. Cellular pathology of progressive atherosclerosis in the WHHL rabbit, an animal model of familial hypercholesterolemia. Arteriosclerosis. 1983;3:87–101
  28. Cybulsky MI, Gimbrone MA. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251:788–791
  29. Rosenfeld ME, Tsukada T, Gown AM, Ross R. Fatty streak initiation in Watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1987;7:9–23
  30. Rosenfeld ME, Tsukada T, Chait A, et al. Fatty streak expansion and maturation in Watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1987;7:24–34
  31. Takano T, Amanuma K, Kimura J, Kanaseki T, Ohkuma S. Involvement of macrophages in accumulation and elimination of cholesterol ester in atherosclerotic aorta. Acta Histochem Cytochem. 1986;19:135–143
  32. Tsukada T, Rosenfeld M, Ross R, Gown AM. Immunocytochemical analysis of cellular components in atherosclerotic lesions: use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis. 1986;6:601–613
  33. Nakazato K, Ishibashi T, Shindo J, Shiomi M, Maruyama Y. Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions. Am J Pathol. 1996;149:1831–1838
  34. Hiltunen TP, Luoma JS, Nikkari T, YlaHerttuala S. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation. 1998;97:1079–1086
  35. Mowri H, Ohkuma S, Takano T. Monoclonal DLR1a/104G antibody recognizing peroxidized lipoproteins in atherosclerotic lesions. Biochim Biophys Acta. 1988;963:208–214
  36. Boyd HC, Gown AM, Wolfbaur G, Chait A. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol. 1989;135:815–825
  37. Frank JS, Fogelman AM. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. J Lipid Res. 1989;30:967–968
  38. Nakajima K, Nakano T, Tanaka A. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin Chim Acta. 2006;367:36–47
  39. Amanuma K, Kanaseki T, Ikeuchi Y, Ohkuma S, Takano T. Studies on fine structure and location of lipids in quick-freeze replicas of atherosclerotic aorta of WHHL rabbits. Virchows Arch A. 1986;410:231–238
  40. Shiomi M, Ito T, Tsukada T, Yata T, Ueda M. Cell composition of coronary and aortic atherosclerotic lesions in WHHL rabbits differ. Arterioscler Thromb. 1994;14:931–937
  41. Shiomi M, Ito T, Tsukada T, et al. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques: effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits. Arterioscler Theromb Vasc Biol. 1995;15:1938–2144
  42. Fukumoto Y, Libby P, Rabkin E, et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits. Circulation. 2001;103:993–999
  43. Shiomi M, Ito T, Hirouchi Y, Enomoto M. Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins. Atherosclerosis. 2001;157:75–84
  44. Shiomi M, Yamada S, Ito T. Atheroma stabilizing effects of simvastatin due to depression of macrophages or lipid accumulation in the atheromatous plaques of coronary atherosclerosis-prone WHHL rabbits. Atherosclerosis. 2005;178:287–294
  45. Shiomi M, Yamada S, Amano Y, Nishimoto T, Ito T. Lapaquistat acetate (TAK-475), a squalene synthase inhibitor, changes macrophage/lipid-rich coronary plaques of WHHLMI rabbits into fibrous lesions. Br J Pharmacol. 2008;154:949–957
  46. Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheromas: a potential mechanism of lesion stabilization. Circulation. 1998;97:2433–2444
  47. Watanabe Y, Ito T, Shiomi M. The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits, an animal model for familial hypercholesterolemia. Atherosclerosis. 1985;56:71–79
  48. Shiomi M, Ito T, Shiraishi M, Watanabe Y. Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis. Atherosclerosis. 1992;96:43–52
  49. Ito T, Shiomi M. Cerebral atherosclerosis occurs spontaneously in homozygous WHHL rabbits. Atherosclerosis. 2001;156:57–66
  50. Shiomi M, Ito T, Yamada S, Kawashima S, Fan J. Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). Arterioscler Thromb Vasc Biol. 2003;23:1239–1244
  51. Van der Wall AC, Becker AE, Van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 2001;104:365–372
  52. Shiomi M, Fan J. Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: questions and quandaries. Curr Opin Lipidol. 2008;19:631–636
  53. Ito T, Yamada S, Shiomi M. Progression of coronary atherosclerosis relates to the onset of myocardial infarction in an animal model of spontaneous myocardial infarction (WHHLMI rabbits). Exp Anim. 2004;53:339–346
  54. Shiomi M, Yamada S, Matsukawa A, Itabe H, Ito T. Invasion of atheromatous plaques into tunica media causes coronary outward remodeling in WHHLMI rabbits. Atherosclerosis. 2008;198:287–293
  55. Liew TV, Ray KK. Intensive statin therapy in acute coronary syndromes. Curr Atheroscler Rep. 2008;10:158–163
  56. Watanabe Y, Ito T, Saeki M, et al. Hypolipidemic effects of CS-500 (ML-236B) in WHHL-rabbit, a heritable animal model for hyperlipidemia. Atherosclerosis. 1981;38:27–31
  57. Tsujita Y, Kuroda M, Shimada Y, et al. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim Biophys Acta. 1986;877:50–60
  58. Watanabe Y, Ito T, Shiomi M, et al. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits. Biochim Biophys Acta. 1988;960:294–302
  59. Kita T, Nagano Y, Yokode M, et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA. 1987;84:5928–5931
  60. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbits. Proc Natl Acad Sci USA. 1987;84:7725–7729
  61. Steen H, Lima JA, Chatterjee S, et al. High-resolution three-dimensional aortic magnetic resonance angiography and quantitative vessel wall characterization of different atherosclerotic stages in a rabbit model. Invest Radiol. 2007;42:614–621
  62. Ogawa M, Ishino S, Mukai T, et al. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med. 2004;45:1245–1250
  63. Iwata A, Miura S, Imaizumi B, Saku K. Measurement of atherosclerotic plaque volume in hyperlipidemic rabbit aorta by intravascular ultrasound. J Cardiol. 2007;50:229–234
  64. Shen J, Herderick E, Cornhill JF, et al. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest. 1996;98:2201–2208
  65. Brousseau ME, Kauffman RD, Herderick EE, et al. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptor in transgenic rabbits. Arterioscler Thromb Vasc Biol. 2000;20:450–458
  66. Fan J, Challah M, Shimoyamada H, et al. Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein(a). J Lipid Res. 2000;41:1004–1012
  67. Koike T, Liang J, Wang X, et al. Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity. J Biol Chem. 2004;279:7521–7529
  68. Sun H, Koike T, Ichikawa T, et al. C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol. 2005;167:1139–1148
  69. Fan J, Watanabe T. Transgenic rabbits as therapeutic protein bioreactors and human disease models. Pharmacol Ther. 2003;99:261–282

PII: S0021-9150(09)00236-6

doi: 10.1016/j.atherosclerosis.2009.03.024

Atherosclerosis
Volume 207, Issue 1 , Pages 1-7 , November 2009

Article Tools

* Image Usage & Resolution